000 01345 a2200409 4500
005 20250513110256.0
264 0 _c19970110
008 199701s 0 0 eng d
022 _a0007-0963
024 7 _a10.1111/j.1365-2133.1996.tb03895.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTosti, A
245 0 0 _aOnychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals.
_h[electronic resource]
260 _bThe British journal of dermatology
_cNov 1996
300 _a799-802 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntifungal Agents
_xtherapeutic use
650 0 4 _aCandidiasis
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aItraconazole
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNails
_xpathology
650 0 4 _aNaphthalenes
_xtherapeutic use
650 0 4 _aOnychomycosis
_xdrug therapy
650 0 4 _aTerbinafine
650 0 4 _aToes
650 0 4 _aTreatment Outcome
700 1 _aPiraccini, B M
700 1 _aStinchi, C
700 1 _aLorenzi, S
773 0 _tThe British journal of dermatology
_gvol. 135
_gno. 5
_gp. 799-802
856 4 0 _uhttps://doi.org/10.1111/j.1365-2133.1996.tb03895.x
_zAvailable from publisher's website
999 _c8969315
_d8969315